Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
J Biol Chem ; 294(44): 16309-16319, 2019 11 01.
Artículo en Inglés | MEDLINE | ID: mdl-31519752

RESUMEN

The tubulin homolog FtsZ is the major cytoskeletal protein in the bacterial cell division machinery, conserved in almost all bacteria, archaea, and chloroplasts. Bacterial FtsZ assembles spontaneously into single protofilaments, sheets, and bundles in vitro, and it also accumulates at the site of division early during cell division, where it forms a dynamic protein complex, the contractile ring or Z-ring. The biochemical properties of FtsZ proteins from many bacteria have been studied, but comparable insights into FtsZs from cyanobacteria are limited. Here, using EM and light-scattering assays, we studied the biochemical and assembly properties of SyFtsZ, the FtsZ protein from the cyanobacterial strain Synechocystis sp. PCC 6803. SyFtsZ had a slow GTPase activity of ∼0.4 GTP/FtsZ molecule/min and assembled into thick, straight protofilament bundles and curved bundles, designated toroids. The assembly of SyFtsZ in the presence of GTP occurred in two stages. The first stage consisted of the assembly of single-stranded straight protofilaments and opened circles; in the second stage, the protofilaments associated into straight protofilament bundles and toroids. In addition to these assemblies, we also observed highly curved oligomers and minirings after GTP hydrolysis or in the presence of excess GDP. The three types of protofilaments of SyFtsZ observed here provide support for the hypothesis that a constriction force due to curved protofilaments bends the membrane. In summary, our findings indicate that, unlike other bacterial FtsZ, SyFtsZ assembles into thick protofilament bundles. This bundling is similar to that of chloroplast FtsZ, consistent with its origin in cyanobacteria.


Asunto(s)
Proteínas Bacterianas/metabolismo , Proteínas del Citoesqueleto/metabolismo , Synechocystis/metabolismo , Proteínas Bacterianas/fisiología , División Celular , Cianobacterias/metabolismo , Proteínas del Citoesqueleto/fisiología , Citoesqueleto/metabolismo , GTP Fosfohidrolasas/metabolismo , Guanosina Trifosfato/metabolismo , Microscopía Electrónica/métodos , Tubulina (Proteína)/metabolismo
2.
Dev Comp Immunol ; 26(9): 849-60, 2002 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-12377224

RESUMEN

There have been few studies aimed at determining the effects of maternal peptide hormones on the developing fetus and even fewer aimed at determining the long-term consequences of abnormalities in maternal hormone exposure. In this study, we have examined the effect of maternal prolactin (PRL) on the production, seeding and long-term function of a T lymphocyte subset for which the precursors are only present during fetal life. Using this system, we can determine long-term consequences of maternal hormone exposure without concern for the subsequent influence of the offspring's endocrine milieu. Recombinant versions of the two major forms of the pituitary hormone, PRL, were administered to rats throughout pregnancy. Administration of a molecular mimic of phosphorylated PRL (PP-PRL) resulted in a marked increase in the level of apoptosis in the thymus of newborn pups, an effect that was not duplicated by administration of unmodified PRL. The increased thymic apoptosis in the animals exposed to PP-PRL resulted in decreased epidermal seeding of gammadeltaT cells and a markedly decreased gammadeltaT cell-modulated epidermal response in the offspring. This decreased gammadeltaT cell modulated response persisted to adulthood. We conclude that maternal PRL composition during pregnancy can have a permanent effect on at least one component of the developing immune system.


Asunto(s)
Preñez/inmunología , Prolactina/inmunología , Receptores de Antígenos de Linfocitos T gamma-delta/inmunología , Subgrupos de Linfocitos T/inmunología , Timo/inmunología , Animales , Animales Recién Nacidos , Apoptosis/inmunología , Dermatitis por Contacto/inmunología , Femenino , Inmunohistoquímica , Imitación Molecular/inmunología , Embarazo , Prolactina/metabolismo , Ratas , Receptores de Antígenos de Linfocitos T gamma-delta/metabolismo , Proteínas Recombinantes , Piel/inmunología , Subgrupos de Linfocitos T/metabolismo , Timo/metabolismo , Células Tumorales Cultivadas
3.
PLoS One ; 4(11): e7863, 2009 Nov 17.
Artículo en Inglés | MEDLINE | ID: mdl-19924236

RESUMEN

BACKGROUND: Both naturally arising Foxp3(+) and antigen-induced Foxp3(-) regulatory T cells (Treg) play a critical role in regulating immune responses, as well as in preventing autoimmune diseases and graft rejection. It is known that antigen-specific Treg are more potent than polyclonal Treg in suppressing pathogenic immune responses that cause autoimmunity and inflammation. However, difficulty in identifying and isolating a sufficient number of antigen-specific Treg has limited their use in research to elucidate the mechanisms underlying their regulatory function and their potential role in therapy. METHODOLOGY/PRINCIPAL FINDINGS: Using a novel class II MHC tetramer, we have isolated a population of CD4(+) Foxp3(-) T cells specific for the autoantigen glutamic acid decarboxylase p286-300 peptide (NR286 T cells) from diabetes-resistant non-obese resistant (NOR) mice. These Foxp3(-) NR286 T cells functioned as Treg that were able to suppress target T cell proliferation in vitro and inhibit type 1 diabetes in animals. Unexpected results from mechanistic studies in vitro showed that their regulatory function was dependent on not only IFN-gamma and nitric oxide, but also on cell contact with target cells. In addition, separating NR286 Treg from target T cells in transwell assays abolished both production of NO and suppression of target T cells, regardless of whether IFN-gamma was produced in cell cultures. Therefore, production of NO, not IFN-gamma, was cell contact dependent, suggesting that NO may function downstream of IFN-gamma in mediating regulatory function of NR286 Treg. CONCLUSIONS/SIGNIFICANCE: These studies identified a unique population of autoantigen-specific Foxp3(-) Treg that can exert their regulatory function dependent on not only IFN-gamma and NO but also cell contact with target cells.


Asunto(s)
Autoantígenos/química , Factores de Transcripción Forkhead/genética , Regulación de la Expresión Génica , Interferón gamma/metabolismo , Óxido Nítrico/metabolismo , Linfocitos T Reguladores/citología , Traslado Adoptivo , Animales , Linfocitos T CD4-Positivos/citología , Proliferación Celular , Antígenos de Histocompatibilidad Clase II/metabolismo , Interleucina-10/metabolismo , Ratones , Ratones Endogámicos NOD , Bazo/citología , Linfocitos T Reguladores/metabolismo
4.
Transfusion ; 48(8): 1550-7, 2008 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-18466178

RESUMEN

BACKGROUND: The Pall eBDS uses oxygen consumption as a surrogate marker for bacterial detection in platelet (PLT) products. This article describes the evaluation of eBDS to detect bacterial contamination in inoculated fresh and stored leukoreduced red cell (RBC) units. STUDY DESIGN AND METHODS: Field studies were conducted at three sites to establish eBDS pouch incubation time and the pass/fail threshold. RBC units were inoculated with each of 12 bacterial species known to cause sepsis at target inocula of either 1 to 15 or 100 colony-forming units (CFUs) per mL. Units were mixed and stored at 2 to 6 degrees C. Samples were taken for culture and eBDS testing weekly from 0 hour to 42 days and incubated for 35 degrees C for 24 to 30, 48, and 72 hours, followed by measurement of percent oxygen content. RESULTS: The studies showed growth of five bacterial species (including Yersinia enterocolitica) in RBC units, while seven bacterial species showed no growth or autosterilized. A pass/fail oxygen threshold of 14.4 percent was determined based on results from noninoculated controls (n = 633) and from inoculated samples (n = 884) after 48 hours of incubation. Detection was 100 percent at all sampling times during refrigerated storage with both 48 and 72 hours of pouch incubation. CONCLUSION: With incubation of eBDS pouches for 48 and 72 hours, 100 percent detection was obtained in 884 samples with bacterial levels of at least 1 CFU per mL, and no false-positive samples were obtained. Based on the bacterial growth patterns, RBC units may be sampled 1 to 3 days after collection for optimal efficacy and read after 48 to 72 hours of incubation of the eBDS sample pouches at 35 degrees C. The Pall eBDS is suited for detection of typical bacterial contaminants in fresh and stored RBCs.


Asunto(s)
Bacteriemia/diagnóstico , Bacterias/aislamiento & purificación , Técnicas Bacteriológicas/métodos , Conservación de la Sangre , Eritrocitos/microbiología , Bacteriemia/prevención & control , Bacteriemia/transmisión , Bacterias/crecimiento & desarrollo , Bacterias/metabolismo , Técnicas Bacteriológicas/normas , Transfusión de Eritrocitos , Infecciones por Bacterias Gramnegativas/diagnóstico , Infecciones por Bacterias Gramnegativas/prevención & control , Infecciones por Bacterias Gramnegativas/transmisión , Infecciones por Bacterias Grampositivas/diagnóstico , Infecciones por Bacterias Grampositivas/prevención & control , Infecciones por Bacterias Grampositivas/transmisión , Humanos , Consumo de Oxígeno , Reproducibilidad de los Resultados , Yersiniosis/diagnóstico , Yersiniosis/prevención & control , Yersiniosis/transmisión , Yersinia enterocolitica/crecimiento & desarrollo , Yersinia enterocolitica/aislamiento & purificación , Yersinia enterocolitica/metabolismo
5.
J Immunol ; 176(6): 3449-60, 2006 Mar 15.
Artículo en Inglés | MEDLINE | ID: mdl-16517713

RESUMEN

Regulatory T cells (Tr cells) play a critical role in inducing immune tolerance. It remains largely unclear how various types of Tr cells perform their regulatory function. We have studied the underlying regulatory mechanism of a population of autoantigen-specific CD4+ Tr cells. These T cells are specific for the glutamic acid decarboxylase p206-220 peptide and are isolated from the diabetes-resistant nonobese-resistant mice. Although these T cells express T-bet and display a Th1 phenotype, they are able to inhibit diabetes. Their regulatory function is dependent on both IFN-gamma and cell contact with target cells. These Tr cells can mediate their cell contact-dependent regulatory function by secreting IFN-gamma which stimulates APCs to produce NO. NO is necessary for the Tr cells to inhibit the proliferation of pathogenic T cells and the development of diabetes. Therefore, we have identified a novel mechanism by which these Tr cells can exert their regulatory function. These results also provide an explanation as to why IFN-gamma may play both pathogenic and immunomodulatory roles in autoimmune diseases.


Asunto(s)
Células Presentadoras de Antígenos/inmunología , Células Presentadoras de Antígenos/metabolismo , Tolerancia Inmunológica/inmunología , Óxido Nítrico/biosíntesis , Linfocitos T Reguladores/inmunología , Linfocitos T Reguladores/metabolismo , Traslado Adoptivo , Animales , Comunicación Celular , Separación Celular , Células Cultivadas , Diabetes Mellitus Experimental/inmunología , Diabetes Mellitus Experimental/metabolismo , Diabetes Mellitus Experimental/prevención & control , Interferón gamma/biosíntesis , Ratones , Óxido Nítrico/metabolismo , Fenotipo , Células TH1/inmunología
6.
J Immunol ; 171(2): 733-44, 2003 Jul 15.
Artículo en Inglés | MEDLINE | ID: mdl-12847240

RESUMEN

Autoantigen-based immunotherapy can modulate autoimmune diabetes, perhaps due to the activation of Ag-specific regulatory T cells. Studies of these regulatory T cells should help us understand their roles in diabetes and aid in designing a more effective immunotherapy. We have used class II MHC tetramers to isolate Ag-specific T cells from nonobese diabetic (NOD) mice and BALB/c mice treated with glutamic acid decarboxylase 65 peptides (p206 and p221). Based on their cytokine secretion profiles, immunization of NOD mice with the same peptide induced different T cell subsets than in BALB/c mice. Treatment of NOD mice induced not only Th2 cells but also IFN-gamma/IL-10-secreting T regulatory type 1 (Tr1) cells. Adoptive transfer experiments showed that isolated tetramer(+) T cells specific for p206 or p221 could inhibit diabetes development. These cells were able to suppress the in vitro proliferation of other NOD mouse T cells without cell-cell contact. They performed their regulatory functions probably by secreting cytokines, and Abs against these cytokines could block their suppressive effect. Interestingly, the presence of both anti-IL-10 and anti-IFN-gamma could enhance the target cell proliferation, suggesting that Tr1 cells play an important role. Further in vivo experiments showed that the tetramer(+) T cells could block diabetogenic T cell migration into lymph nodes. Therefore, treatment of NOD mice with autoantigen could induce Th2 and Tr1 regulatory cells that can suppress the function and/or block the migration of other T cells, including diabetogenic T cells, and inhibit diabetes development.


Asunto(s)
Autoantígenos/inmunología , Diabetes Mellitus Tipo 1/inmunología , Diabetes Mellitus Tipo 1/prevención & control , Epítopos de Linfocito T/inmunología , Activación de Linfocitos , Subgrupos de Linfocitos T/inmunología , Células Th2/inmunología , Traslado Adoptivo , Secuencia de Aminoácidos , Animales , Anticuerpos Bloqueadores/farmacología , Anticuerpos Monoclonales/farmacología , Antígenos CD , Antígenos de Diferenciación/biosíntesis , Autoantígenos/biosíntesis , Linfocitos T CD4-Positivos/inmunología , Linfocitos T CD4-Positivos/metabolismo , Antígeno CTLA-4 , Separación Celular , Células Cultivadas , Técnicas de Cocultivo , Citocinas/inmunología , Citocinas/metabolismo , Diabetes Mellitus Tipo 1/enzimología , Regulación hacia Abajo/inmunología , Epítopos de Linfocito T/biosíntesis , Glutamato Descarboxilasa/inmunología , Antígenos de Histocompatibilidad Clase II/biosíntesis , Isoenzimas/inmunología , Activación de Linfocitos/inmunología , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos NOD , Ratones SCID , Ratones Transgénicos , Datos de Secuencia Molecular , Fragmentos de Péptidos/biosíntesis , Subgrupos de Linfocitos T/metabolismo , Subgrupos de Linfocitos T/trasplante , Células Th2/metabolismo
7.
J Immunol ; 173(11): 6777-85, 2004 Dec 01.
Artículo en Inglés | MEDLINE | ID: mdl-15557171

RESUMEN

Immunization of NOD mice with autoantigens such as glutamic acid decarboxylase (GAD) 221-235 peptide (p221) can induce Ag-specific CD4(+) T regulatory (Tr) cells. However, it is unclear whether these Tr cells acquire their regulatory capacity due to immunization or whether they are constitutively harbored in unimmunized naive mice. To address this question, we used an I-Ag7 tetramer to isolate p221-specific T cells from naive NOD mice (N221(+) cells) after peptide-specific in vitro expansion. The N221(+) T cells produced IFN-gamma and IL-10, but very little IL-4, in response to p221 stimulation. These T cells could function as regulatory cells and inhibit in vitro proliferation of diabetogenic BDC2.5 cells. This suppressive activity was cell contact-independent and was abrogated by Abs to IL-10 or IL-10R. Interestingly, IL-2 produced by other T cells present in the cell culture induced unactivated N221(+) T cells to exhibit regulatory activities involving production of IL-10. In vivo, N221(+) cells inhibited diabetes development when cotransferred with NOD splenocytes into NOD/scid recipients. Together, these results demonstrate that p221-specific IL-10-dependent Tr cells, including Tr type 1 cells, are present in naive NOD mice. The use of spontaneously arising populations of GAD peptide-specific Tr cells may represent a promising immunotherapeutic approach for preventing type 1 diabetes.


Asunto(s)
Linfocitos T CD4-Positivos/enzimología , Linfocitos T CD4-Positivos/inmunología , Diabetes Mellitus Tipo 1/inmunología , Diabetes Mellitus Tipo 1/prevención & control , Epítopos de Linfocito T/inmunología , Glutamato Descarboxilasa/inmunología , Epítopos Inmunodominantes/inmunología , Interleucina-10/fisiología , Traslado Adoptivo , Animales , Linfocitos T CD4-Positivos/trasplante , Separación Celular/métodos , Citocinas/metabolismo , Epítopos de Linfocito T/biosíntesis , Femenino , Glutamato Descarboxilasa/biosíntesis , Epítopos Inmunodominantes/biosíntesis , Ratones , Ratones Endogámicos NOD , Ratones SCID , Fragmentos de Péptidos/biosíntesis , Fragmentos de Péptidos/inmunología , Estado Prediabético/inmunología , Estado Prediabético/prevención & control , Bazo/citología , Bazo/enzimología , Bazo/inmunología , Bazo/trasplante , Subgrupos de Linfocitos T/enzimología , Subgrupos de Linfocitos T/inmunología , Subgrupos de Linfocitos T/trasplante
8.
Cell Tissue Res ; 309(3): 429-37, 2002 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-12195299

RESUMEN

We have investigated the individual roles of unmodified prolactin (U-PRL) and a mimic of phosphorylated PRL (S179D PRL) in mammary development. Recombinant versions of the PRLs were delivered to rats throughout pregnancy at a rate of 6 microg/24 h per rat and to non-pregnant females at a rate of 24 microg/24 h per rat. Measurement of progesterone, corticosterone, and estradiol showed no effect of the administered PRLs on the levels of these other mammotropic hormones. Histological and morphometric analysis showed U-PRL to cause mammary growth, whereas S179D PRL inhibited growth. Molecular analysis demonstrated decreased beta-casein expression in the mammary glands of the U-PRL-treated animals at term and increased beta-casein expression in the mammary glands of the S179D PRL-treated animals. Superior beta-casein gene expression in response to S179D PRL versus U-PRL was confirmed in HC11 cells. We conclude that U-PRL is important for growth, whereas S179D PRL promotes at least one measure of differentiated function in the mammary gland.


Asunto(s)
Caseínas/genética , Regulación de la Expresión Génica/efectos de los fármacos , Glándulas Mamarias Animales/fisiología , Prolactina/análogos & derivados , Prolactina/farmacología , Sustitución de Aminoácidos , Animales , División Celular/efectos de los fármacos , Corticosterona/sangre , Estradiol/sangre , Femenino , Humanos , Glándulas Mamarias Animales/citología , Glándulas Mamarias Animales/efectos de los fármacos , Fosforilación , Embarazo , Progesterona/sangre , Ratas , Ratas Sprague-Dawley , Proteínas Recombinantes/farmacología
9.
J Immunol ; 170(8): 4011-20, 2003 Apr 15.
Artículo en Inglés | MEDLINE | ID: mdl-12682229

RESUMEN

Nonobese diabetic (NOD) mice expressing the BDC2.5 TCR transgene are useful for studying type 1 diabetes. Several peptides have been identified that are highly active in stimulating BDC2.5 T cells. Herein, we describe the use of I-Ag7 tetramers containing two such peptides, p79 and p17, to detect and characterize peptide-specific T cells. The tetramers could stain CD4(+) T cells in the islets and spleens of BDC2.5 transgenic mice. The percentage of CD4(+), tetramer(+) T cells increased in older mice, and it was generally higher in the islets than in the spleens. Our results also showed that tetAg7/p79 could stain a small population of CD4(+) T cells in both islets and spleens of NOD mice. The percentage of CD4(+), tetramer(+) T cells increased in cells that underwent further cell division after being activated by peptides. The avidity of TCRs on purified tetAg7/p79(+) T cells for tetAg7/p79 was slightly lower than that of BDC2.5 T cells. Although tetAg7/p79(+) T cells, like BDC2.5 T cells, secreted a large quantity of IFN-gamma, they were biased toward being IL-10-producing cells. Additionally, <3% of these cells expressed TCR Vbeta4. In vivo adoptive transfer experiments showed that NOD/scid recipient mice cotransferred with tetAg7/p79(+) T cells and NOD spleen cells, like mice transferred with NOD spleen cells only, developed diabetes. Therefore, we have generated Ag-specific tetramers that could detect a heterogeneous population of T cells, and a very small number of NOD mouse T cells may represent BDC2.5-like cells.


Asunto(s)
Epítopos de Linfocito T/inmunología , Activación de Linfocitos/inmunología , Ratones Transgénicos/inmunología , Fragmentos de Péptidos/inmunología , Subgrupos de Linfocitos T/química , Subgrupos de Linfocitos T/inmunología , Traslado Adoptivo , Animales , Linfocitos T CD4-Positivos/química , Linfocitos T CD4-Positivos/inmunología , Linfocitos T CD4-Positivos/trasplante , Movimiento Celular/genética , Movimiento Celular/inmunología , Separación Celular , Diabetes Mellitus Tipo 1/genética , Diabetes Mellitus Tipo 1/inmunología , Relación Dosis-Respuesta Inmunológica , Epítopos de Linfocito T/administración & dosificación , Epítopos de Linfocito T/metabolismo , Glutamato Descarboxilasa/administración & dosificación , Glutamato Descarboxilasa/inmunología , Glutamato Descarboxilasa/metabolismo , Antígenos de Histocompatibilidad Clase II/administración & dosificación , Antígenos de Histocompatibilidad Clase II/inmunología , Antígenos de Histocompatibilidad Clase II/metabolismo , Islotes Pancreáticos/química , Islotes Pancreáticos/inmunología , Islotes Pancreáticos/metabolismo , Isoenzimas/administración & dosificación , Isoenzimas/inmunología , Isoenzimas/metabolismo , Activación de Linfocitos/genética , Ratones , Ratones Biozzi , Ratones Endogámicos BALB C , Ratones Endogámicos NOD , Ratones SCID , Fragmentos de Péptidos/administración & dosificación , Fragmentos de Péptidos/síntesis química , Unión Proteica/genética , Unión Proteica/inmunología , Bazo/química , Bazo/inmunología , Bazo/trasplante , Subgrupos de Linfocitos T/trasplante
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA